Article
Genetic associations of docetaxel-based chemotherapy-induced myelosuppression in Chinese Han population.
Journal of clinical pharmacy and therapeutics - 1 Apr 2020
Ren Weihua, Zhou Chenxi, Liu Yedong, Su Keli, Jia Li, Chen Luan, Li Mo, Ma Jingsong, Zhou Wei, Zhang Suli, Zhang Di, Cong Zhiliang, Niu Xuecai, Zhang Shengui, Shen Lu, Huai Cong, Sun Xiaofang, Li Guorong, Qin Shengying, Guo Liang
Abstract excerpt
WHAT IS KNOWN AND OBJECTIVE: Myelosuppression, an adverse drug reaction (ADR), often causes medical treatment termination in cancer patients. It has been known that genetic components, such as single-nucleotide polymorphisms (SNPs), influence the risk of myelosuppression at the individual-patient level. However, due to ethnic variation in frequency of genetic polymorphisms, results reported in Caucasian patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
